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ABSTRACT
Background: Pandemic inﬂuenza H1N1/09 emerged in
April 2009 and spread widely in Australia and New
Zealand. Although an unprecedented number of cases
required intensive care, comparative community-based
studies with seasonal inﬂuenza strains have not shown
any signiﬁcant differences in clinical symptoms or
severity.
Methods: The authors performed active surveillance
on conﬁrmed inﬂuenza-related admissions and
compared the clinical proﬁle of patients with pandemic
H1N1/09 inﬂuenza and patients with seasonal inﬂuenza
at eight hospitals in Australia and one hospital in New
Zealand.
Results: During the 1 July and 30 November 2009,
560 patients with conﬁrmed inﬂuenza were admitted,
of which 478 had H1N1/09, and 82 had other seasonal
strains. Patients with H1N1/09 inﬂuenza were younger,
were more likely to have fever and were more likely to
be pregnant but less likely to have chronic obstructive
pulmonary disease and ischaemic heart disease than
patients with seasonal strains. Other clinical features
and comorbidities were reported in similar
proportions. Admission to intensive care was required
in 22% of patients with H1N1/09 inﬂuenza and 12% in
patients with other strains. Hospital mortality was 5%
in patients with H1N1 inﬂuenza.
Conclusions: The clinical features of H1N1/09
inﬂuenza and seasonal strains were similar in
hospitalised patients. A higher proportion of patients
had comorbidities than had been reported in
community-based studies. Although the overall
mortality was similar, the authors found evidence that
H1N1/09 caused severe disease in a higher proportion
of hospitalised patients.
BACKGROUND
Pandemic inﬂuenza H1N1/09 emerged in
late April 2009 and was the predominant
inﬂuenza strain globally in 2009/2010.
1 The
ﬁrst imported cases in Australia and New
Zealand were reported in mid-April and early
May 2009, and spread widely, coinciding with
the southern winter in June. The few
comparative studies of the clinical features of
H1N1/09 inﬂuenza and other seasonal
strains suggest that clinical features are
generally similar. However, the large
comparative studies were community-based,
and analysis of hospital-based studies was
limited by the small numbers of patients.
2e6
A recent study from Western Australia
concluded that the severity of illness, assessed
by rates of hospitalisation and hospital length
of stay, was similar.
5 In contrast, intensive care
units in Australia and New Zealand reported
an increased demand for resources; while
this may in part have been due to high
numbers of community cases, there was
also unprecedented use of extracorporeal
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ARTICLE SUMMARY
Article focus
- We performed an observational study of patients
with H1N1/09 and seasonal strains of inﬂuenza in
2009, based on active surveillance at nine
sentinel hospitals.
- We explored differences between patients with
H1N1/09 inﬂuenza infection and those with
seasonal inﬂuenza infections.
Key messages
- This study found that the clinical features of
H1N1/09 inﬂuenza were similar in hospitalised
patients, similar to previous community-based
studies.
- The ﬁnding that H1N1/09 inﬂuenza was associ-
ated with more severe disease reconciles
apparently contradictory data suggesting no
differences in community studies, but unprece-
dented use of critical care services.
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Open Access Researchmembrane oxygenation (ECMO) in a small number of
patients.
78
We initiated active surveillance for patients hospital-
ised with inﬂuenza and pneumonia at nine hospitals in
Australia and New Zealand to deﬁne the spectrum of
disease associated with severe inﬂuenza. In this study, we
aimed to explore differences in risk factors, clinical
features and outcome between patients with H1N1/09
inﬂuenza and other seasonal strains of inﬂuenza.
METHODS
We conducted active surveillance in eight hospitals in
Australia and one hospital in New Zealand for labora-
tory-conﬁrmed inﬂuenza from 1 July 2009 to 31
November 2009. This formed part of a real-time hospital-
based surveillance system (Inﬂuenza Complications
Alert Network; FluCAN) for inﬂuenza and community-
acquired pneumonia.
9 Data collection was retrospective
from July 1 until early August 2009 and prospective
subsequently. Patients were identiﬁed from lists of
admissions and/or laboratory results, and included if
they had laboratory-conﬁrmed inﬂuenza. Site investiga-
tors audited 10% of records selected at random. Study
sites included large regional and metropolitan hospitals
(but did not include specialty paediatric or obstetric
hospitals) in six of the eight Australian states and terri-
tories and in Hamilton, New Zealand. Data were
collected on standardised clinical record forms. In all
study sites, inﬂuenza was diagnosed using nucleic-acid
detection from respiratory samples, with subtyping
performed at a reference laboratory for each state. While
we did not record seasonal subtypes, previous studies
have reported that of the 414 seasonal inﬂuenza strains
typed in Australia between January and December 2009,
67% were subtype A/H3, 28% were subtype A/H1N1,
and 5% were inﬂuenza B.
10
We deﬁned severe obesity as a body mass index of
>35 kg/m
2. Indigenous status, smoking and symptoms
were self-reported. Pneumonia was deﬁned as the pres-
ence of respiratory symptoms consistent with pneumonia
together with radiological evidence of consolidation
reported by a radiologist or site investigator. Diabetes,
asthma, chronic obstructive pulmonary disease, chronic
liver disease, chronic neurological disease and chronic
renal disease were recorded as comorbidities if these
diagnoses were documented in the patient notes.
Immunosuppression was deﬁned as oral steroid use or
other immunosuppressive medication, organ trans-
plantation, HIV infection or cancer chemotherapy. The
length of stay included the time from admission to the
sentinel hospital (not including time spent at other
hospitals where patients were transferred from other
hospitals) to discharge (including hospital-in-the-home
services, but not including time in other hospitals if
patients were transferred for further care).
Continuous measures were compared using the
ManneWhitney U test, and categorical variables using
the c
2 test or Fisher exact test as appropriate. Multivar-
iate logistic regression models examining risk factors for
intensive-care unit (ICU) admission were constructed
using backwards selection (with a p value threshold of
0.1 for selection of variables). Analyses included only
patients where data were ascertained (denominator data
are provided in tables).
Ethical approval to perform this study was obtained at
all sites; consent was sought to follow-up patients after
30 days by telephone. This study was supported by the
Australian National Health and Medical Research
Council; the funder did not have a role in study design,
analysis or interpretation.
RESULTS
Between 1 July 2009 and 30 November 2009, 560 patients
were admitted to the sentinel hospitals with laboratory-
conﬁrmed inﬂuenza. Of these, 478 (85%) of patients
had infection with H1N1/09, and 82 (15%) had infec-
tion with seasonal inﬂuenza strains (all other strains of
inﬂuenza A). The number of cases varied by site; 47
(8.4%) cases were reported in Victorian sites, 37 (6.6%)
in New South Wales, 108 (19%) in Queensland, 158
(28%) in West Australia, 101 (18%) in South Australia,
85 (15%) in Tasmania and 24 (4.2%) in New Zealand.
The median age of patients admitted was 48 years
(IQR 30, 59 years), and 288 (51%) were female. Patients
with H1N1/09 inﬂuenza were younger, and a higher
proportion were female (table 1). There were 82 (16%)
indigenous patients of the 546 patients where ethnic
status was known; this included 65 Australian Aboriginal
people, 10 Torres Strait Islanders (one of whom was both
Aboriginal and a Torres Strait Islander) and eight Maori
ARTICLE SUMMARY
Strengths and limitations of this study
- This surveillance system was rapidly established, and initial
data collection was retrospective from the medical record
where symptoms were not always well documented. Despite
high levels of awareness in medical staff, clinical testing criteria
were operating during the period of the study and were likely to
bias the proportion of patients reporting fever and respiratory
symptoms. Nucleic-acid detection using PCR is regarded as
the gold standard for diagnosis, but our experience with
discordant results on repeated testing suggested that it may
not be completely sensitive. This study does not encompass
the full duration of the epidemic which was waning in several
states (notably Victoria and New South Wales) at the
commencement of the study period. Although several hospitals
provided maternity and paediatric services, these patient
groups are likely to be under-represented in this series.
The population served by the sentinel hospitals is not
known, and thus we were not able to establish a disease
incidence rate.
- This large study captured all admissions with inﬂuenza at
multiple hospitals across Australia and New Zealand. All cases
were conﬁrmed by nucleic acid detection with clinical details
collected by research staff.
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Clinical features of H1N1/09 inﬂuenzapeople. Fourteen admissions (2.6%) were healthcare
workers. The source of infection was known in 130
(223%) cases, was from the household in 76 cases,
involved nosocomial infection in 27 cases and was
reported to follow interstate or overseas travel in 27
cases.
Risk factors
The most common reported comorbidities included
asthma (28%), chronic obstructive pulmonary disease
(COPD) (17%), immunosuppression (17%) and dia-
betes (18%). In the 424 patients where smoking status
was recorded, 30% were current smokers and 24% were
past smokers. In the 322 patients where an estimate of
height and weight was documented, 23% were severely
obese. A higher proportion of patients with H1N1/09
inﬂuenza were pregnant, and a lower proportion of
patients had COPD and ischaemic heart disease than
those with seasonal inﬂuenza (table 2).
In the 216 patients with asthma or COPD, 68 (31%)
had radiologically conﬁrmed pneumonia (compared
with 39% in patients without asthma or COPD, p¼0.07),
and 15% were admitted to ICU (compared with 23% in
other patients, p¼0.015). The 30-day mortality of
patients with asthma or COPD was 4%.
Clinical features
The reason for admission was recorded in 541 patients;
this included respiratory disease in 470 (86%) patients,
non-respiratory complications (including obstetric
complications and exacerbation of underlying medical
problems) in 47 (9%) and other reasons in 24 cases. The
largest group of patients presented to outpatients,
emergency departments or hospital-based ‘ﬂu clinics’
(n¼249, 44%). Other sources of referral were smaller
hospitals for further management (n¼115, 21%) and
general practitioners (n¼80, 14%).
Presenting symptoms could not be ascertained for all
patients, but where reported, cough was the most
common symptom (92%); fever was present in only 80%
of patients. Fever and sore throat were reported in
a higher proportion of patients with H1N1/09 inﬂuenza
compared with patients with other strains (table 3).
Fever with one respiratory symptom (cough, nasal
congestion, sore throat or rhinorrhoea) was present in
410 of the 557 patients (76%) where any of these
symptoms were ascertained.
Table 1 Demographics characteristics in patients with H1N1 inﬂuenza and other seasonal strains
H1N1/09 Other strains p Value
No 478 82
Age (median; IQR) 47 (29 to 58) 58 (38 to 74) 0.06
Female 258 (54%) 30 (37%) 0.004
Indigenous
ATSI: Aboriginal and Torres
Strait Islander (Australia)
68/453 (15%) 7/71 (10%) 0.28
Maori (NZ) 4/13 (31%) 4/9 (44%) 0.62
Nosocomial 23 (4.8%) 4 (4.9%) 1.00
Healthcare worker 13/459 (2.8%) 1 (1.3%) 0.7
Table 2 Risk factors in patients with H1N1 inﬂuenza and other seasonal strains
H1N1/09 Other strains p Value
Smoking
Current 109/363 (30%) 18/61 (30%) 0.1
Past 82 (23%) 21/61 (34%)
Non-smoker 172 (47%) 22/61 (36%)
Asthma 137/470 (29%) 17/80 (21%) 0.17
Chronic obstructive pulmonary disease 73/468 (16%) 20/80 (25%) 0.05
Diabetes 82/475 (17%) 16/81 (20%) 0.63
Pregnancy* 43/256* (9.5%) 2/30* (2.5%) 0.046
Liver disease 29/474 (4.9%) 4/81 (6.2%) 0.80
Immunosuppressed 80/473 (17%) 12/80 (15%) 0.74
Current malignancy 43/473 (9%) 13/80 (16%) 0.69
Congestive cardiac failure 31/472 (6.6%) 8/80 (10%) 0.24
Ischaemic heart disease 45/473 (9.7%) 17/81 (21%) 0.006
Severe obesity 68/276 (25%) 7/46 (15%) 0.19
Chronic neurological disease 52 (11%) 8/81 (10%) 0.84
Chronic renal disease 33/472 (7.0%) 7/81 (8.6%) 0.64
*Expressed as proportion of female patients.
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Clinical features of H1N1/09 inﬂuenzaPneumonia and secondary bacterial infection
Of the 560 patients with inﬂuenza, 204 (36%) had
radiologically conﬁrmed consolidation. Symptoms more
common in patients with pneumonia included fever
(86% vs 76%, p<0.001) and dyspnoea (83%, vs 65%,
p<0.001). Cough (95% vs 90%), diarrhoea (18% vs
13%) and chest pain (35% vs 32%) were reported in
similar proportions in patients with and without pneu-
monia. Asthma (23% vs 30%, p¼0.06) was less common
in patients with pneumonia; similar proportions
reported COPD, diabetes, immunosuppression, cardiac
failure or ischaemic heart disease. Independent clinical
predictors of pneumonia included fever (OR 1.7, 95%
CI 1.1 to 2.8), dyspnoea (OR 2.9, 95% CI 1.9 to 4.6);
a history of asthma (OR 0.53, 95% CI 0.35 to 0.82) was
protective against pneumonia. Pneumonia was less
common in patients with H1N1/09 (35%) than other
seasonal strains (45%, p¼0.08), although this difference
was not statistically signiﬁcant.
Blood cultures were taken in 291 patients, and
a signiﬁcant pathogen was isolated in 15 patients and
included Staphylcoccus aureus (n¼8), pneumococcus
(n¼4), Escherichia coli (n¼1) and Enterobacter sp (n¼1).
Sputum cultures were taken in 164 patients with pneu-
monia; signiﬁcant pathogens isolated included Pseudo-
monas spp (n¼9), Haemophilus inﬂuenzae (n¼6),
pneumococcus (n¼5), Moraxella catarrhalis, Serratia sp
and Klebsiella sp (all n¼1). Positive cultures were
reported in similar proportions in patients with H1N1/
09 inﬂuenza compared with those with other strains
(table 1). A higher proportion of patients with H1N1/09
inﬂuenza received antiviral therapy; similar proportions
received antibiotics.
Intensive-care admission
A higher proportion of patients with H1N1/09 inﬂuenza
required admission to intensive care (table 4). Of the
116 patients admitted to ICU, 111 required ventilatory
support (including 28 patients requiring non-invasive
ventilation, 79 requiring invasive ventilation and four
requiring ECMO). Vasopressor and/or inotropic
support was required in 60 patients.
On univariate analysis, factors associated with ICU
admission included older age, pregnancy, liver disease
Table 3 Clinical and diagnostic features in patients with H1N1 inﬂuenza and other seasonal strains
H1N1/09 Other strains p Value
Fever 383/470 (81%) 57/80 (71%) 0.04
Nasal congestion 45/339 (13%) 6/46 (14%) 1.0
Rhinorrhoea 114/358 (32%) 15/51 (29%) 0.87
Sore throat 162/382 (42%) 15/53 (28%) 0.05
Cough 420/458 (92%) 70/76 (93%) 1.0
Chest pain 137/413 (33%) 22/69 (32%) 0.89
Dyspnoea 323/452 (71%) 55/74 (74%) 0.67
Myalgia 188/375 (50%) 27/59 (46%) 0.57
Diarrhoea 58/394 (15%) 11/69 (16%) 0.85
Consolidation on
chest x-ray
167/478 (35%) 37/82 (45%) 0.08
Positive blood culture 12/251 (5%) (E coli 1, S aureus 7,
S pneumoniae 3, E faecium 1)
3/40 (8%) (Enterobacter cloacae 1,
S aureus 1, S pneumoniae 1)
0.44
Positive sputum culture 19/145 (13%) (Ps aeruginosa 8,
S pneumoniae 4, H. inﬂuenzae 4,
E coli 1, Moraxella 1, Serratia 1)
5/19 (26%) (H. inﬂuenzae 2, Klebsiella 1,
Ps. aeruginosa 1, S pneumoniae 1)
0.15
Table 4 Management and outcome in patients with H1N1 inﬂuenza and other seasonal strains
H1N1/09 Other strains p Value
Oseltamivir 384/472 (81%) 42/77 (55%) <0.001
Zanamavir 6/441 (1%) 1/73 (1%) 1.0
Any antibiotics 381/469 (81%) 71/80 (89%) 0.10
Intensive-care-unit admission 106/478 (22%) 10/82 (12%) 0.03
Intensive-care-unit interventions
Extracorporeal membrane oxygenation 4 (4%) 0 1.0
Mechanical ventilation 72 (68%) 7 (70%) 1.0
Non-invasive ventilation 26 (25%) 2 (20%) 1.0
Vasopressor 53 (50%) 5 (50%) 1.0
Hospital length of stay (IQR) 5 days (2 to 10 days) 4 days (2 to 9 days) 0.44
Hospital mortality 26 (5%) 0 0.02
30 day mortality 30 (6%) 3 (4%) 0.35
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Clinical features of H1N1/09 inﬂuenzaand obesity (table 5). Patients with pneumonia
commonly required admission to ICU; 41% of patients
with pneumonia required ICU, compared with 8% of
patients with no radiological evidence of consolidation.
On multivariate analysis, liver disease and pregnancy
were independently associated with ICU admission.
Obesity was not included in the multivariate model
owing to missing data, but in the 81 patients admitted to
ICU where body weight was assessed, 26 patients (32%)
were obese.
Outcome
The median duration of admission was 5 days (IQR 2,
10 days) and was similar for patients with H1N1/09
inﬂuenza and other seasonal strains (table 4). For
patientsadmittedtoICU,themediandurationofhospital
admission was 14 days (IQR 7, 25 days). The in-hospital
mortality was higher in patients with H1N1/09 inﬂuenza
(5%) than in patients with other inﬂuenza strains (no
deaths), but the 30-day mortality was similar (6% vs 4%).
DISCUSSION
This study compares the clinical features and outcomes
of hospitalised patients with pandemic H1N1/09 inﬂu-
enza and those with seasonal strains at nine hospitals in
Australia and New Zealand. A study comparing
community patients with seasonal and pandemic H1N1/
09 inﬂuenza in Western Australia found similar hospi-
talisation rates, hospital length of stay and comorbidities,
and concluded that the clinical severity of disease of
pandemic H1N1/09 inﬂuenza was similar to that of
seasonal inﬂuenza.
5 Although case series of patients with
H1N1/09 inﬂuenza may provide some information on
clinical features,
11e13 comparisons with previously
published literature are difﬁcult to interpret owing to
differences in health-seeking behaviour, and policies
regarding diagnostics, hospital admission and treatment.
Similar to other studies, we found that patients with
H1N1 inﬂuenza were younger, were more likely to report
fever but had otherwise similar symptoms and comor-
bidities to patients with other inﬂuenza strains.
5 61 4
Differences between this study of hospitalised patients
and other community-based studies are likely to reﬂect
the severity of illness; cough and dyspnoea were more
common and rhinorrhoea less common.
35Differences
in comorbidities are difﬁcult to compare with other
studies owing to differences in deﬁnitions, but in general
comorbidities, particularly current smoking, renal
disease and obesity appeared to be more common in
hospitalised patients.
5 Consistent with previous hospital
studies,
6 we also found obesity to be more common in
patients with H1N1 inﬂuenza, although ascertainment of
these data was incomplete. We found pregnancy and
liver disease to occur in a higher proportion of patients
with H1N1/09 inﬂuenza (and to be risk factors for ICU
admission) and ischaemic heart disease and COPD to
occur in a lower proportion. The differences in co-
morbdities may in part reﬂect the younger age of
patients with H1N1/09 infection.
Table 5 Factors associated with intensive-care-unit admission
Univariate OR Multivariate-adjusted OR p Value
Age (per decade) 0.90 (0.81 to 1.00) 0.05
Sex
Female 1 (referent) 0.26
Male 0.79 (0.52 to 1.2)
Inﬂuenza strain
H1N1/09 2.1 (1.0 to 4.1) 0.04 1.9 (0.9 to 4.0) 0.08
Other strain 1
Radiologically conﬁrmed pneumonia 6.7 (4.2 to 10.5) <0.001 NI (in causal pathway)
Smoking NI (missing data)
Non-smoker 1
Current 0.87 (0.50 to 1.4) 0.61
Past 0.51 (0.26 to 0.97) 0.04
Asthma 0.62 (0.38 to 1.03) 0.07
Chronic obstructive pulmonary disease 0.48 (0.25 to 0.94) 0.03 0.54 (0.27 to 1.07) 0.08
Diabetes 0.91 (0.53 to 1.59) 0.76
Pregnancy 2.6 (1.3 to 4.9) 0.004 2.5 (1.3 to 4.8) 0.007
Liver disease 2.3 (1.1 to 4.9) 0.03 2.8 (1.3 to 5.9) 0.008
Immunosuppression 0.92 (0.53 to 1.6) 0.78
Current malignancy 0.92 (0.46 to 1.84) 0.82
Cardiac failure 0.83 (0.36 to 1.9) 0.74
Ischaemic heart disease 0.54 (0.25 to 1.2) 0.13
Obesity 1.9 (1.1 to 3.2) 0.03 NI
Chronic neurological disease 0.40 (0.17 to 0.97) 0.12
Chronic renal disease 1.3 (0.63 to 2.8) 0.46
NI, not included in ﬁnal model owing to the high proportion of missing data. HosmereLemeshow goodness-of-ﬁt statistic for ﬁnal model, p¼0.82.
NI, not included in ﬁnal model.
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Clinical features of H1N1/09 inﬂuenzaImportantly, we found some evidence that the severity
of illness was greater in patients hospitalised with H1N1/
09 inﬂuenza compared with those hospitalised with
seasonal inﬂuenza. Patients with H1N1/09 inﬂuenza
were more likely to require ICU admission, although
after adjusting for underlying risk factors, this difference
was no longer statistically signiﬁcant. The proportion of
patients requiring ICU was similar to that reported in
other Australian series
4 12 but much higher than in
a series reported in Hong Kong.
6 This is unlikely to
represent differences in ICU admission criteria, as over
70% patients required ventilation or ECMO. A higher
proportion of patients with H1N1/09 inﬂuenza required
mechanical ventilation and ECMO; the in-hospital
mortality (but not 30 day mortality) was higher.
Our ﬁndings highlight the importance of lower-respi-
ratory-tract involvement, regardless of strain, as a marker
of severity of disease, with 40% of patients with consoli-
dation requiring admission to intensive care. Radiolog-
ical evidence of pneumonia or pneumonitis was found in
similar proportions of patients with H1N1 inﬂuenza and
other inﬂuenza strains. Although bacterial pneumonia is
notoriously underdiagnosed using blood and sputum
culture, in the majority of patients no bacterial pathogens
were identiﬁed This is consistent with previous studies
suggesting that bacterial pneumonia following H1N1/09
inﬂuenza is less common than viral pneumonitis.
15 We
found COPD to be negatively associated with ICU
admission. Potential explanations include differing
admission policies for ICU in patients with pre-existing
respiratory compromise and a lower threshold for
admission to hospital for patients with viral exacerbations
of COPD; the latter is supported by the lower proportion
of patients with asthma requiring ICU admission.
There were several limitations to this study. This
surveillance system was rapidly established, and the
initial data collection was retrospective from the medical
record where symptoms were not always well docu-
mented. Despite high levels of awareness in medical
staff, clinical testing criteria were operating during the
period of the study,
16 and were likely to bias the
proportion of patients reporting fever and respiratory
symptoms. Thus, the clinical syndrome of inﬂuenza-like
illness is likely to be less sensitive than that described
here. Nucleic-acid detection using PCR is regarded as
the gold standard for diagnosis, but our experience with
discordant results on repeated testing suggested that it
may not be completely sensitive. This has implications
for surveillance systems and for infection-control
measures in hospitalised patients. This study does not
encompass the full duration of the epidemic which was
waning in several states (notably Victoria and New South
Wales) at the commencement of the study period.
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Although several hospitals provided maternity and
paediatric services, these patient groups are likely to be
under-represented in this series. Despite this, we are
conﬁdent that the admissions to sentinel hospitals are
representative of patients admitted elsewhere, as the
characteristics of the patients in this report are compa-
rable with national surveillance data.
9 However, the
population served by the sentinel hospitals is not known,
and thus we were not able to establish an incidence rate
of infection which has been calculated elsewhere.
19
CONCLUSION
H1N1/09 inﬂuenza was the predominant strain of
inﬂuenza in hospitalised patients; the younger proﬁle of
patients reﬂected widespread population susceptibility.
A higher proportion of patients with H1N1/09 inﬂuenza
were obese, were pregnant but had lower rates of COPD
and ischaemic heart disease compared with patients with
other inﬂuenza strains. In reconciling community-based
studies that have not found any differences in severity
with the experience of intensive care units, patients
requiring hospitalisation with H1N1/09 were more likely
to require admission to intensive care than those with
infection with other strains. The case death of patients
hospitalised with inﬂuenza was around 5% with a 30-day
mortality similar in patients with H1N1/09 inﬂuenza
and seasonal strains.
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